Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Sell

C

Wave Life Sciences Ltd. Ordinary Shares (WVE)

Pharmaceutical Preparations

https://www.wavelifesciences.com

WAVE Life Sciences Ltd is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.

7 STRAITS VIEW, #12-00, MARINA ONE EAST TOWER
SINGAPORE, U0

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/11/2015

Market Cap

713,501,360

Shares Outstanding

119,010,000

Weighted SO

119,137,742

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

ARWR --.--%

CTMX --.--%

ASMB --.--%

NLTX --.--%

VECT --.--%

ICVX --.--%

APLS --.--%

ITOS --.--%

TCRX --.--%

Beta

-1.1290

Last Div

0.0000

Range

3.5-7.67

Chg

-0.0900

Avg Vol

900833

Mkt Cap

713501360

Exch

NASDAQ

Country

SG

Phone

65 6236 3388

DCF Diff

6.6200

DCF

-0.0300

Div Yield

0.0000

P/S

6.4570

EV Multiple

-7.6258

P/FV

168.5000

Div Yield %

0.0000

P/E

-10.0823

PEG

-0.2998

Payout

0.0000

Current Ratio

0.9939

Quick Ratio

0.9939

Cash Ratio

0.8893

DSO

4.2611

DIO

0.0000

Op Cycle

4.2611

DPO

753.1990

CCC

-748.9378

Gross Margin

0.9204

Op Margin

-0.7574

Pretax Margin

-0.6711

Net Margin

-0.6650

Eff Tax Rate

-0.1096

ROA

-0.3519

ROE

-6.5791

ROCE

-2.3450

NI/EBT

0.9909

EBT/EBIT

0.8861

EBIT/Rev

-0.7574

Debt Ratio

0.1383

D/E

6.5670

LT Debt/Cap

0.8316

Total Debt/Cap

0.8678

Int Coverage

-29.0601

CF/Debt

-4.4374

Equity Multi

47.4910

Rec Turnover

85.6589

Pay Turnover

0.4846

Inv Turnover

999999.9999

FA Turnover

3.4411

Asset Turnover

0.5292

OCF/Share

-0.9892

FCF/Share

-0.9971

Cash/Share

1.1886

OCF/Sales

-1.1595

FCF/OCF

1.0080

CF Coverage

-4.4374

ST Coverage

-17.8852

CapEx Coverage

-125.7158

Div&CapEx Cov

-125.7158

P/BV

168.5000

P/B

168.5000

P/S

6.4570

P/E

-10.0823

P/FCF

-5.5246

P/OCF

-5.7824

P/CF

-5.7824

PEG

-0.2998

P/S

6.4570

EV Multiple

-7.6258

P/FV

168.5000

DPS

0.0000

Latest Headlines (EST)

Benzinga Oct 20, 21:22 Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? GlobeNewswire Inc. Jan 03, 08:30 Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference PennyStocks Dec 19, 10:11 Penny Stocks To Buy Now? 4 To Watch Before 2024 GlobeNewswire Inc. Dec 15, 08:30 Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy GlobeNewswire Inc. Nov 22, 08:30 Wave Life Sciences to Present at 6áµ—Ê° Annual Evercore ISI HealthCONx Conference GlobeNewswire Inc. Nov 09, 07:30 Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Revenue Product Segmentation